Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,107	$ 1,535
Accounts receivable	838	961
Prepaid expenses and other current assets	586	853
Derivative asset	0	0
Total current assets	2,531	3,349
Property and equipment, net	65	136
Operating lease right-of-use asset	0	146
TOTAL ASSETS	2,596	3,631
Current liabilities:
Accounts payable	3,955	2,039
Accrued expenses	1,104	1,242
Deferred revenue	0	63
Current portion of long-term debt	25	75
Operating lease liability	0	146
Warrant liability	0	2,351
Total current liabilities	5,084	5,916
Long-term debt	0	26
TOTAL LIABILITIES	5,084	5,942
Stockholders’ equity (deficit):
Convertible preferred stock (Series A), par value of $0.001 per share; 10,000,000 shares authorized, 10 shares issued and outstanding as of December 31, 2024, and no shares authorized, issued or outstanding as of December 31, 2023; with aggregate liquidation preference of $1,750,000 and $0 as of December 31, 2024 and December 31, 2023, respectively	1,665	0
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of December 31,2024 and December 31,2023; 2,676,642 and 892,622 shares issued as of December 31,2024 and December 31,2023 respectively; 2,676,637 and 892,617 shares outstanding as of December 31,2024 and December 31,2023, respectively	1	0
Additional paid-in capital	354,418	337,627
Treasury stock, at cost; 5 shares of common stock as of December 31, 2024, and December 31, 2023, respectively	(11)	(11)
Accumulated deficit	(358,561)	(339,927)
TOTAL STOCKHOLDERS' EQUITY/(DEFICIT)	(2,488)	(2,311)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 2,596	$ 3,631